Shareable Research Card

REGN - REGENERON PHARMACEUTICALS, INC. Common Stock, Par or Stated Value Per Share

This metric view shows REGN - REGENERON PHARMACEUTICALS, INC. common stock, par or stated value per share history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q3 2012
Latest reported value
0.001

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Open stable link Open company facts

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 30 Sep 2012
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q3 2012.
  • Latest reported value on this page: 0.001.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Create account to save this filer Open company facts

Latest update

Latest update for Common Stock, Par or Stated Value Per Share

New filing available

Latest reported common stock, par or stated value per share: 0.001. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

30 Sep 2012

Page type

Metric history

Latest period

Q3 2012

Institutional portfolio context was refreshed from a 13F filing filed on 08 May 2026.

Open recent updates hub Open company facts

Benchmark Context

How Common Stock, Par or Stated Value Per Share compares with peers

REGENERON PHARMACEUTICALS, INC. is outside the visible top 120 companies for common stock, par or stated value per share in the current sample.

Compared with

Compared with 120 companies reporting common stock, par or stated value per share in USD/shares. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Common Stock, Par or Stated Value Per Share is roughly flat versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Mar 2010 to 30 Apr 2026.
  • Nearby companies in this sample: Singularity Future Technology Ltd. and Oaktree Gardens OLP, LLC.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Open company facts

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Financial Metric Page

REGENERON PHARMACEUTICALS, INC.: Common Stock, Par or Stated Value Per Share

Latest period: Q3 2012. Period end: 30 Sep 2012. Units: USD/shares and PerShare. Frequency: quarterly.

Face amount or stated value per share of common stock.

What This Metric Tells You

  • Shows reported common stock, par or stated value per share over 30 Jun 2010 - 30 Sep 2012.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 12 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Common Stock, Par or Stated Value Per Share levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Report period Next step
1 Singularity Future Technology Ltd. (sgly) 50,000,000 Instant - 31 Mar 2022 Open Singularity Future Technology Ltd. Common Stock, Par or Stated Value Per Share
2 Oaktree Gardens OLP, LLC 5,115,000 Instant - 30 Jun 2023 Open Oaktree Gardens OLP, LLC Common Stock, Par or Stated Value Per Share
3 ID Auto, Inc. 1,125,000 Instant - 31 Oct 2016 Open ID Auto, Inc. Common Stock, Par or Stated Value Per Share
4 BRIGHTHOUSE LIFE INSURANCE Co 25,000 Instant - 31 Mar 2026 Open BRIGHTHOUSE LIFE INSURANCE Co Common Stock, Par or Stated Value Per Share
5 AB Private Credit Investors Corp 24,000 Instant - 26 May 2017 Open AB Private Credit Investors Corp Common Stock, Par or Stated Value Per Share
6 EASTERN GAS TRANSMISSION & STORAGE, INC. 10,000 Instant - 30 Jun 2022 Open EASTERN GAS TRANSMISSION & STORAGE, INC. Common Stock, Par or Stated Value Per Share

Metric Details

Metric
Common Stock, Par or Stated Value Per Share (CommonStockParOrStatedValuePerShare)
Frequency coverage
quarterly
Metric identity 1 identity field
Taxonomy
us-gaap
Metric coverage 3 source fields
Units tracked
USD/shares and PerShare
History range
30 Jun 2010 - 30 Sep 2012
Facts on this page
12
How to read it 1 detail
Metric definition
Face amount or stated value per share of common stock.
Source evidence 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Change (%)
Common Stock, Par or Stated Value Per Share, Quarterly (PerShare)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Common Stock, Par or Stated Value Per Share (USD/shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2012 0.001 0 0% 30 Sep 2012 10-Q 24 Oct 2012 2012 Q3
Q2 2012 0.001 0 0% 30 Jun 2012 10-Q 25 Jul 2012 2012 Q2
Q1 2012 0.001 0 0% 31 Mar 2012 10-Q 26 Apr 2012 2012 Q1
Q4 2011 0.001 0 0% 31 Dec 2011 10-Q 24 Oct 2012 2012 Q3
Q3 2011 0.001 0 0% 30 Sep 2011 10-Q 27 Oct 2011 2011 Q3
Q2 2011 0.001 0 0% 30 Jun 2011 10-Q 28 Jul 2011 2011 Q2
Q1 2011 0.001 31 Mar 2011 10-Q 03 May 2011 2011 Q1
Q4 2010 0.001 31 Dec 2010 10-Q 27 Oct 2011 2011 Q3
Q3 2010 0.001 30 Sep 2010 10-Q 28 Oct 2010 2010 Q3
Q2 2010 0.001 30 Jun 2010 10-Q 28 Jul 2010 2010 Q2

REGENERON PHARMACEUTICALS, INC. Quarterly Common Stock, Par or Stated Value Per Share (PerShare)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2011 0.001 0 0% 31 Dec 2011 10-K 21 Feb 2012 2011 FY
Q4 2010 0.001 31 Dec 2010 10-K 21 Feb 2012 2011 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .